Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity

Table 1 Characteristics of patients at inclusion

	Patients (n = 232)
Demographics and history
Female sex, n (%)	164 (71)
Age at inclusion (years)	63 (52–72)
Symptom duration at inclusion (months)	7 (5–10)
Time to first DMARD ^a (months)	5 (3–7)
Traditional CVD risk factors
Hypertension, n (%)	66 (28)
Diabetes, n (%)	14 (6)
Hyperlipidaemia, n (%)	19 (8)
BMI (kg/m²)	25 (22–28)
Cigarette smoking status
Current smokers, n (%)	78 (35)
Previous smokers, n (%)	75 (34)
Never smokers, n (%)	69 (31)

Median (IQR) given unless otherwise stated
DMARD, disease-modifying antirheumatic drugs; CVD, cardiovascular disease; BMI, body mass index; IQR, inter quartile range
Missing numbers were as follows: Time to DMARD = 22, BMI = 10, Cigarette smoking status = 10
^a Duration from rheumatoid arthritis symptom onset to start of first DMARD.

ISSN: 2520-1026